We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanom... Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. Show more
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a...
In collaboration with leading GI experts, Castle has also planned several educational sessions at DDW 2024, including a product theater and two American Society for Gastrointestinal Endoscopy...
This marks the fourth consecutive year that Castle has earned a MedTech Breakthrough Award for its innovative testing solutions Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health...
Oral presentation at ARVO shares ground-breaking findings from the ongoing Collaborative Ocular Oncology Group (COOG) study 2 (COOG2) of patients with uveal melanoma (UM) Castle Biosciences, Inc...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new data supporting the utility of its DecisionDx-SCC...
Q1 2024 revenue increased 74% over Q1 2023 to $73 million Q1 2024 total test reports increased 40% over Q1 2023 Raising full-year 2024 revenue guidance to $255-265 million from $235-240 million...
The Company is proud to collaborate on a number of additional initiatives during the month of May Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.27 | -1.10159118727 | 24.51 | 25.1 | 23.78 | 264956 | 24.20400136 | CS |
4 | 5.2 | 27.3109243697 | 19.04 | 25.91 | 18.76 | 273400 | 23.04827639 | CS |
12 | -0.07 | -0.287947346771 | 24.31 | 25.91 | 17.42 | 256115 | 21.62193683 | CS |
26 | 4.74 | 24.3076923077 | 19.5 | 25.91 | 17.42 | 240613 | 21.52152709 | CS |
52 | 1.51 | 6.64320281566 | 22.73 | 26.7 | 9.2601 | 399599 | 18.02761845 | CS |
156 | -30.83 | -55.9832939895 | 55.07 | 78.92 | 9.2601 | 281624 | 28.05362471 | CS |
260 | 4.24 | 21.2 | 20 | 107.69 | 9.2601 | 253744 | 34.37057932 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions